23/02/2015
In >95% of patients, high triglycerides reflect the burden of the effects of more than 30 genes involved in triglyceride pathways.
28/11/2014
EAS is committed to supporting the next generation of atherosclerosis researchers. In the Glasgow 2015 Congress Scientific Programme there are exciting new opportunities for young investigators to give oral and poster communications. We want the best and brightest young scientists from around the world to be able to participate in these sessions, and to support […]
12/09/2014
Os autores (Wenhui Zhao, Jing Guan, Ronald Horswell, Weiqin Li, Yujie Wang, Xiaocheng Wu e Gang Hu) tinham como objetivo de investigar a relação entre o colesterol HDL (HDL-C) e o risco de cancro em doentes com diabetes tipo 2(DM2).
14/07/2014
O INFARMED emitiu uma Circular Informativa N.º 092/CD/8.1.7. a 11/04/2014 com Recomendações de utilização dos fármacos Modificadores do eixo renina angiotensina:
01/04/2014
Growth differentiation factor 15 (GDF-15) is a relatively new biomarker that predicts mortality in patients with chronic stable angina or acute coronary syndrome. However, the association of GDF-15 with cardiovascular (CV) events and the mechanisms of this association are not well understood.
01/04/2014
Studies of prehypertension and mortality are controversial after adjusting for other cardiovascular risk factors. This meta-analysis sought to evaluate the association of prehypertension with all-cause and cardiovascular disease (CVD) mortality.
01/04/2014
To derive and validate a clinical rule that stratifies the risk of cardiac complications in patients hospitalized for community-acquired pneumonia (CAP) and compare its performance to the pneumonia severity index (PSI) score.
01/04/2014
To examine 18-year trends in short-term and long-term stroke mortality and the prognostic influence of comorbidity.
01/04/2014
Nonsteroidal anti-inflammatory drugs (NSAIDs) other than aspirin have been linked to heart failure, salt retention, adverse ventricular remodeling, and thrombosis. We therefore sought to assess their impact on cardiovascular events in outpatients with stable atherothrombotic disease.
06/02/2014
A Sociedade Internacional de Aterosclerose (IAS) atualizou as suas recomendações sobre o tratamento da hipercolesterolemia e dislipidemias para reduzir o risco de doença cardiovascular aterosclerótica (ASCVD) em Dezembro 2013.
